Phibro Animal Health (PAHC) Tops Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health (PAHC) PT Raised to $35 at Guggenheim on 'Beat and Raise' Q1
November 12, 2014 10:27 AM ESTGuggenheim analyst Louise Chen reiterated a Buy rating and boosted her price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $35.00 (from $24.00) following 'beat and raise' Q1 results.
Chen said the Q1 positives that support their Buy thesis are: 1) Good volume... More



